Skip to content

ARCHITECT 1L82-25Recalls & reported problems

Abbott Ireland Diagnostics · ARCHITECT AUSAB Reagent Kit · Class 2

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00380740001513), received between Oct 25, 2017 and Oct 25, 2017 — classified as 1 malfunction.

The most frequently reported specific device problem is “Incorrect Or Inadequate Test Results” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Incorrect Or Inadequate Test Results1

Patient problems

  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 25, 2017Incorrect Or Inadequate Test Results; Incorrect Or Inadequate Test Results

    THE CUSTOMER OBSERVED (B)(6) RESULTS WHILE USING THE ARCHITECT AUSAB REAGENTS. THE FOLLOWING DATA WAS PROVIDED FOR ONE PATIENT (MIU/ML). (B)(6). PER THE PRODUCT PACKAGE INSERT, WHEN INITIAL RESULT IS LESS THAN OR EQUAL TO 8.00 TO LESS THAN 12.00 MIU/ML THE INTERPRETATION IS GRAYZONE AND INSTRUCTS THE USER TO RETEST IN DUPLICATE. NONREACTIVE RESULTS (LESS THAN 8.00 MIU/ML) AND REACTIVE RESULTS (GREATER THAN OR EQUAL TO 12.00 MIU/ML) DO NOT REQUIRE RETEST. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 6977588 ↗

Other Test, hepatitis b (b core, be antigen, be antibody, b core igm) devices

All Test, hepatitis b (b core, be antigen, be antibody, b core igm) devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page